跳转至内容
Merck
CN

SCP0079

Caspase 2/3 Inhibitor

≥94% (HPLC)

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C24H37N5O13
分子量:
603.58
UNSPSC Code:
12352200
NACRES:
NA.21
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

assay

≥94% (HPLC)

form

lyophilized

composition

Peptide Content, ≥80%

storage condition

protect from light

storage temp.

−20°C

Application

Caspase 2/3 Inhibitor (Ac-LDESD-CHO) is used to study the active site recognition of penta5 (P5) position substrates by caspases 2 and 3.

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Andreas Schweizer et al.
The Journal of biological chemistry, 278(43), 42441-42447 (2003-08-16)
The cell death protease caspase-2 has recently been recognized as the most apical caspase in the apoptotic cascade ignited during cell stress signaling. Cytotoxic stress, such as that caused by cancer therapies, leads to activation of caspase-2, which acts as
Guoxing Fu et al.
Apoptosis : an international journal on programmed cell death, 13(11), 1291-1302 (2008-09-10)
Caspase-3, -6 and -7 cleave many proteins at specific sites to induce apoptosis. Their recognition of the P5 position in substrates has been investigated by kinetics, modeling and crystallography. Caspase-3 and -6 recognize P5 in pentapeptides as shown by enzyme
Ling Wang et al.
Cancer research, 68(12), 4640-4648 (2008-06-19)
Kaposi's sarcoma-associated herpesvirus (KSHV) is associated with three different human malignancies, including Kaposi's sarcoma (KS), primary effusion lymphoma, and multicentric Castleman's disease. The KS lesion is of endothelial cell in origin and is highly dependent on autocrine and paracrine factors

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持